Solventum (SOLV) Competitors $74.10 -0.03 (-0.04%) Closing price 03:59 PM EasternExtended Trading$73.38 -0.73 (-0.98%) As of 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SOLV vs. GEHC, PHG, ZBH, SNN, PEN, STVN, IRTC, BLCO, GKOS, and SLNOShould you be buying Solventum stock or one of its competitors? The main competitors of Solventum include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry. Solventum vs. Its Competitors GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Smith & Nephew SNATS Penumbra Stevanato Group iRhythm Technologies Bausch + Lomb Glaukos Soleno Therapeutics GE HealthCare Technologies (NASDAQ:GEHC) and Solventum (NYSE:SOLV) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, media sentiment, risk, earnings and profitability. Is GEHC or SOLV more profitable? GE HealthCare Technologies has a net margin of 11.22% compared to Solventum's net margin of 4.52%. Solventum's return on equity of 29.93% beat GE HealthCare Technologies' return on equity.Company Net Margins Return on Equity Return on Assets GE HealthCare Technologies11.22% 23.93% 6.29% Solventum 4.52%29.93%6.65% Do analysts prefer GEHC or SOLV? GE HealthCare Technologies presently has a consensus target price of $88.40, suggesting a potential upside of 15.36%. Solventum has a consensus target price of $85.44, suggesting a potential upside of 15.31%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts clearly believe GE HealthCare Technologies is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GE HealthCare Technologies 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.91Solventum 1 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.42 Do insiders & institutionals have more ownership in GEHC or SOLV? 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.3% of GE HealthCare Technologies shares are owned by insiders. Comparatively, 0.1% of Solventum shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has preferable valuation & earnings, GEHC or SOLV? GE HealthCare Technologies has higher revenue and earnings than Solventum. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGE HealthCare Technologies$19.97B1.75$1.99B$4.8815.70Solventum$8.25B1.56$478M$2.1634.31 Does the media prefer GEHC or SOLV? In the previous week, GE HealthCare Technologies and GE HealthCare Technologies both had 18 articles in the media. GE HealthCare Technologies' average media sentiment score of 1.45 beat Solventum's score of 0.83 indicating that GE HealthCare Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GE HealthCare Technologies 16 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Solventum 7 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, GEHC or SOLV? GE HealthCare Technologies has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, Solventum has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500. SummaryGE HealthCare Technologies beats Solventum on 12 of the 15 factors compared between the two stocks. Get Solventum News Delivered to You Automatically Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SOLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SOLV vs. The Competition Export to ExcelMetricSolventumMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$12.85B$7.54B$5.75B$21.52BDividend YieldN/A2.84%5.89%3.50%P/E Ratio34.3177.1076.6629.87Price / Sales1.5635.67445.6853.54Price / Cash7.4624.0537.2224.68Price / Book4.337.1713.944.54Net Income$478M$241.92M$3.29B$999.97M7 Day Performance4.01%1.41%0.63%1.44%1 Month Performance3.64%1.96%4.32%4.66%1 Year Performance2.45%2.12%84.13%14.11% Solventum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SOLVSolventum2.0898 of 5 stars$74.100.0%$85.44+15.3%+3.3%$12.85B$8.25B34.3122,000Trending NewsAnalyst ForecastGEHCGE HealthCare Technologies4.229 of 5 stars$78.16+3.2%$88.55+13.3%-10.6%$34.58B$19.97B16.0253,000Positive NewsPHGKoninklijke Philips3.3951 of 5 stars$27.88-0.2%N/A-9.5%$26.89B$17.86B146.7166,678Short Interest ↓ZBHZimmer Biomet4.8137 of 5 stars$104.74-0.9%$111.00+6.0%-7.7%$20.75B$7.68B25.4817,000Positive NewsSNNSmith & Nephew SNATS2.4444 of 5 stars$38.38+0.8%$36.00-6.2%+18.7%$16.81B$5.81B17.7717,349PENPenumbra4.7858 of 5 stars$285.15+1.3%$302.93+6.2%+40.2%$11.12B$1.19B75.844,500STVNStevanato Group2.1729 of 5 stars€25.53+5.7%N/A+42.3%€7.73B€1.15B47.285,521Gap UpIRTCiRhythm Technologies1.1864 of 5 stars$187.07+3.3%$163.82-12.4%+136.6%$6.01B$591.84M-63.852,000Positive NewsBLCOBausch + Lomb2.1191 of 5 stars$15.50+3.3%$15.56+0.3%-16.3%$5.49B$4.89B-19.8813,500Positive NewsGKOSGlaukos4.6414 of 5 stars$91.83-2.2%$127.42+38.7%-33.7%$5.27B$383.48M-55.66780Positive NewsSLNOSoleno Therapeutics4.442 of 5 stars$72.30+3.6%$115.09+59.2%-5.8%$3.84BN/A-17.4630Short Interest ↑ Related Companies and Tools Related Companies GEHC Alternatives PHG Alternatives ZBH Alternatives SNN Alternatives PEN Alternatives STVN Alternatives IRTC Alternatives BLCO Alternatives GKOS Alternatives SLNO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SOLV) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
